Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan

Study ID: NCT07384377
Start Date: 2026-02-06
End Date: 2028-06-15
Study Type

Interventional

Study Phase

Phase3

No. of Participants

123

Intervention / Treatment

JSKN003

Physician choiced treatment, include: TAS-102, Regorafenib, Fruquintinib.

Sponsor

Shanghai Jant-Bio Sci.

Source: clinicaltrials.gov

Share:
Add to list

Screening and Support for Youth (SASY)

Study ID: NCT06419595
Start Date: 2026-11-01
End Date: 2028-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

220

Intervention / Treatment

Behavioral: Screening and Support for Youth (SASY) Multi-component Platform: includes screening, feedback, single session intervention, and resource information

Behavioral: Screening and Support for Youth (SASY) Multi-component Platform: includes screening, feedback, single session intervention, and resource information

Sponsor

Cambridge Health Alliance

Source: clinicaltrials.gov

Share:
Add to list

Modular Intervention for Depression Study

Study ID: NCT07380451
Start Date: 2026-04-01
End Date: 2028-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Modular Intervention for Depression Therapy (MIND Therapy)

Psychotherapy as Usual (TAU)

Sponsor

Pontifical Catholic University of Chile

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders

Study ID: NCT06652802
Start Date: 2026-06-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

74

Intervention / Treatment

Nurse-Conducted Brief Intervention (NCBI). supplemented with mobile based application.

Nurse-Conducted Brief Intervention (NCBI)

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Natrunix in HLA-B27 Positive Subjects With Axial Spondyloarthritis

Study ID: NCT06526377
Start Date: 2026-08-15
End Date: 2027-04-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Natrunix

Placebo

Sponsor

XBiotech, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Comparison of Postoperative Pain After Pulpotomy Performed With Versus Without Dental Operating Microscope in Carious Mature Permanent Teeth

Study ID: NCT07373977
Start Date: 2026-02-10
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

82

Intervention / Treatment

Using dental operating microscope

Sponsor

Chulalongkorn University

Source: clinicaltrials.gov

Share:
Add to list

Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer

Study ID: NCT07330583
Start Date: 2026-03
End Date: 2032-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

22

Intervention / Treatment

Stereotactic body radiation treatment (SBRT)

Sponsor

AHS Cancer Control Alberta

Source: clinicaltrials.gov

Share:
Add to list

Loneliness as Risk Factor for Dementia

Study ID: NCT07211945
Start Date: 2026-03
End Date: 2028-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment
Sponsor

Health Consortium of Alt Penedès and Garraf

Source: clinicaltrials.gov

Share:
Add to list

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461) in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

Study ID: NCT07147231
Start Date: 2026-03-31
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

86

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Cemiplimab

Computed Tomography

Magnetic Resonance Imaging

Pidnarulex

Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A COPD Data Registry for Participants With Frequent Exacerbations

Study ID: NCT07059273
Start Date: 2026-05-18
End Date: 2030-11-18
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3000

Intervention / Treatment
Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list